| Literature DB >> 24260716 |
Jayanthi Manne1, Marina Markova, Linda D Siracusa, Sergio A Jimenez.
Abstract
The Tight Skin mouse is a genetically induced animal model of tissue fibrosis caused by a large in-frame mutation in the gene encoding fibrillin-1 (Fbn-1). We examined the influence of gender on the collagen content of tissues in C57BL/6J wild type (+/+) and mutant Tight Skin (Tsk/+) mice employing hydroxyproline assays. Tissue sections were stained with Masson's trichrome to identify collagen in situ. Adult Tsk/+ mice skin contains ~15% more collagen, on average, than skin from +/+ mice of the same gender. The heart of Tsk/+ males had significantly more collagen than that of +/+ males. No significant gender differences were found in lungs and kidney collagen content. Overall, the collagen content of Tsk/+ males and +/+ males was higher than that of their Tsk/+ and +/+ female counterparts, respectively. Our data confirm increased deposition of collagen in skin and hearts of Tsk/+ mice; however, the effects of the Tsk mutation on collagen content are both tissue specific and gender specific. These results indicate that comparative studies of collagen content between normal and Tsk/+ mice skin and internal organs must take into account gender differences caused by expression of the androgen receptor.Entities:
Year: 2013 PMID: 24260716 PMCID: PMC3821901 DOI: 10.1155/2013/436053
Source DB: PubMed Journal: Biochem Res Int
Hydroxyproline content in skin of B6 +/+ and B6 Tsk/+ mice.
| Group | Sex | Age in weeks | Number of mice | Site 1 | Site 2 | Site 3 |
|---|---|---|---|---|---|---|
| B6 +/+ | F | 24–27 | 6 | 45.7 ± 1.6 | 57.0 ± 2.1 | 61.1 ± 1.6 |
| B6 | F | 23–25 | 6 | 51.1 ± 2.5 | 68.0 ± 2.5 | 73.9 ± 3.7 |
|
|
|
| ||||
|
| ||||||
| B6 +/+ | M | 24–27 | 6 | 133.0 ± 7.8 | 149.4 ± 5.3 | 155.4 ± 5.1 |
| B6 | M | 24–27 | 6 | 138.3 ± 5.4 | 167.8 ± 4.8 | 174.3 ± 7.4 |
|
|
|
| ||||
Hydroxyproline content is expressed as µg/4 mm skin punch. F: females; M: males. Site 1: proximal; Site 2: middle; Site 3: distal dorsum. S.E: standard error. Statistical comparisons were performed using the t-test following analysis of variance (see Section 2).
Figure 1Hydroxyproline content of 4 mm skin punches from B6 Tsk/+ and B6 +/+ mice. Site 1: proximal (light grey bar); Site 2: middle (white bar); Site 3: distal dorsum (dark grey bar). F: females and M: males. Hydroxyproline values are expressed as μg/4 mm skin punch. The standard error of the mean is shown.
Figure 2Histopathology of tissues from wild type +/+ and mutant Tsk/+ mice. The genotype and gender of the mice are shown at the top. The tissue is shown at the left of the figure. Skin, lung, heart, and kidney samples from mice were removed, fixed, paraffin-embedded, sectioned, and stained with Masson's trichrome. Collagen staining appears in blue. Compare the thickness of the collagen-containing dermal layer and the hypodermal or superficial fascia layer (shown in red brackets) beneath the panniculus carnosus in the skin. The age of the mice ranged between 23 and 27 weeks. Magnification is 200x.
Hydroxyproline content in lung, heart, and kidney of B6 +/+ and B6 Tsk/+ mice.
| Genotype | Sex | Age in weeks | Number of mice | Lung | Heart | Kidney (L) | Kidney (R) |
|---|---|---|---|---|---|---|---|
| B6 +/+ | F | 24–27 | 5 | 272.6 ± 10.0 | 106.8 ± 6.2 | 120.0 ± 4.9 | 114.4 ± 4.3 |
| B6 | F | 23–25 | 6 | 264.5 ± 17.3 | 115.7 ± 3.5 | 120.5 ± 1.9 | 113.2 ± 6.8 |
|
|
|
|
| ||||
|
| |||||||
| B6 +/+ | M | 24–27 | 6 | 316.7 ± 9.0 | 106.2 ± 5.4 | 152.2 ± 5.5 | 141.5 ± 3.4 |
| B6 | M | 24–27 | 6 | 325.2 ± 20.0 | 127.5 ± 9.1 | 149.5 ± 12.6 | 145.8 ± 9.8 |
|
|
|
|
| ||||
Hydroxyproline is expressed as μg/per organ content in lung, heart, and kidney. F: females; M: males. L: left; R: right. S.E: standard error. Statistical analysis was performed using t-test following analysis of variance.
Summary of published data showing skin thickness and hydroxyproline content in Tsk/+ and control mice.
| Strain background | Genotype | No. of mice studied | Age | Gender | Dermal thickness (mm) | Fold change in dermal thicknessb | Fold change in collagen or hydroxyproline contentb | Reference |
|---|---|---|---|---|---|---|---|---|
| B10.D2(58N)/Sn |
| 5 | 6 months | NGa | 1.1 ± 0.1 |
Jimenez et al., 1984 [ | ||
| B10.D2(58N)/Sn |
| 5 | 6 months | NG | 2.2 ± 0.1 | 2.0 | 2.5 | |
|
| ||||||||
| NZB |
| 2 | NG | NG |
Bocchieri et al., 1993 [ | |||
| NZB |
| 2 | NG | NG | 2.3 | |||
|
| ||||||||
| C57BL/6 |
| 5 | 2-3 months | NG | ~0.180 |
Ong et al., 1999 [ | ||
| BALB/c, C57BL/6 |
| 5 | 2-3 months | NG | ~0.380 | 2.1 | ||
| BALB/c, C57BL/6 |
| 5 | 2-3 months | NG | ~0.190 | 1.0 | ||
| BALB/c, C57BL/6 |
| 5 | 2-3 months | NG | ~0.290 | 1.6 | ||
| BALB/c, C57BL/6 |
| 5 | 2-3 months | NG | ~0.160 | 0.8 | ||
| BALB/c, C57BL/6 |
| 5 | 2-3 months | NG | ~0.170 | 0.9 | ||
|
| ||||||||
| C57BL/6 |
| 6 | NG | NG | 0.132 ± 0.042 |
McGaha et al., 2001 [ | ||
| C57BL/6 |
| 13 | NG | NG | 0.228 ± 0.072 | 1.7 | 2.0 | |
| BALB/c, C57BL/6 |
| 9 | NG | NG | 0.243 ± 0.088 | 1.8 | 1.5 | |
| BALB/c, C57BL/6 |
| 9 | NG | NG | 0.135 ± 0.031 | 1.0 | 0.9 | |
| C57BL/6 |
| 16 | NG | NG | 0.164 ± 0.078 | 1.2 | 0.8 | |
| C57BL/6 |
| 3 | NG | NG | 0.120 ± 0.018 | 0.9 | 0.8 | |
|
| ||||||||
| C57BL/6 |
| 6 | 3 months | NG | 0.118 ± 0.021 |
Kodera et al., 2002 [ | ||
| C57BL/6 |
| 13 | 3 months | NG | 0.232 ± 0.089 | 1.9 | ||
| BALB/c, C57BL/6 |
| 6 | 3 months | NG | 0.327 ± 0.081 | 2.7 | ||
| BALB/c, C57BL/6 |
| 12 | 3 months | NG | 0.205 ± 0.091 | 1.7 | ||
| BALB/c, C57BL/6 |
| 27 | 3 months | NG | 0.143 ± 0.042 | 1.2 | ||
| BALB/c, C57BL/6 |
| 5 | 3 months | NG | 0.162 ± 0.023 | 1.4 | ||
| BALB/c, C57BL/6 |
| 5 | 3 months | NG | 0.139 ± 0.019 | 1.2 | ||
|
| ||||||||
| C57BL/6 |
| NG | 3 months | Female | ~0.160 |
Saito et al., 2002 [ | ||
| C57BL/6 |
| NG | 3 months | Female | ~0.390 | 1.1 | 1.25 | |
| C57BL/6, 129 |
| NG | 3 months | Female | ~0.160 | 1.0 | 1.0 | |
| C57BL/6, 129 |
| NG | 3 months | Female | ~0.320 | 1.0 | 1.1 | |
|
| ||||||||
| C57BL/6 |
| 11 | NG | 0.206 ± 0.021 |
Del Prete et al., 2004 [ | |||
| C57BL/6 |
| 8 | NG | 0.182 ± 0.089 | ||||
|
| ||||||||
| C57BL/6 |
| 23 | 6 weeks | Male | ~0.8 |
Baxter et al., 2005 [ | ||
| C57BL/6 |
| 34 | 6 weeks | Male | ~1.5 | 2.0 | ||
aNG: not given. bFold change is shown compared to control.